“We have four bankruptcies and three companies on the ropes, and not many will invest in this space”
Resistant to Antibiotic Resistance: Why is Bankruptcy a Reality for Many Small to Mid-sized Commercial-stage Antibiotic Companies?
by Cara He, BA | June 8, 2020
Contraception: How Far Are We From Gender Equality?
by Malek Chouchane, PhD | January 8, 2020
Birth control refers to the use of devices, medications, surgical procedures, and sexual behaviors to prevent pregnancies.
Survival Strategy in Biopharma – Mergers and Acquisitions
by Kiran Deshmukh, MS | December 19, 2019
Success in the biopharmaceuticals industry relies on the continuous development of novel drug molecules.
How 3D Bioprinting Complements the Healthcare and Pharmaceutical Industries
by Tzu-Wei (Vicki) Tsao, PhD | December 13, 2019
With recent technological advances, 3D printing has gained increasing acceptance in industries as varied as architecture, automotive and aerospace.
From Conception to Product: How Instrumentation Companies Connect with Bench Scientists
by Marie-Cécilia Duvernoy, PhD | June 27, 2019
Any scientist who has spent time at the bench of a biology laboratory knows that protocols can be long, repetitive and complex. With innovative research and discoveries constantly demanding higher throughput
A Virtual Supplement to Ease Your Pain
by Tanvi Sinha, PhD | June 24, 2019
Pain, in its very essence, is a universal experience, yet unique to each individual. It has been defined as ‘an unpleasant sensory and emotional experience associated with actual or potential tissue damage’
How Artificial Intelligence is Bolstering Healthcare Advances in Therapeutics Development
by Stella Belonwu, BS | June 14, 2019
Artificial intelligence (AI) is currently one of the biggest buzz words within technology innovation. In the simplest terms, AI is a branch of computer science that involves training computers